Cellular Biology |
From the Second Department of Internal Medicine, Faculty of Medicine (D.N., E.S., M.S., M.K., A.G., M.O., Y.H.), Department of Urology, Faculty of Medicine (H.N.), Department of Geriatrics, Faculty of Medicine (M.Y.), University of Tokyo, Japan, and Division of Cardiovascular Research, St. Elizabeths Medical Center, Tufts University School of Medicine (T.M., K.W.), Boston, Mass.
Correspondence to Etsu Suzuki, MD, PhD, The Second Department of Internal Medicine, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. E-mail suzuki-2im{at}h.u-tokyo.ac.jp
| Abstract |
|---|
|
|
|---|
Key Words: cell cycle transcription factors kidney gene transfer cyclin-dependent kinases
| Introduction |
|---|
|
|
|---|
The GATA transcription factors comprise 6 isoforms. Among them, the GATA-1/-2/-3 genes are mainly expressed in hematopoietic cells, whereas the GATA-4/-5/-6 genes are predominantly expressed in the heart and gastrointestinal tract.3 Gene disruption experiments of each GATA transcription factor have shown that each GATA gene has distinct functions.4 5 6 7 8 9 We have recently shown that the GATA-6 gene was expressed in cultured human and rat VSMCs and that its expression is rapidly downregulated when quiescent cultured VSMCs are stimulated by serum mitogens to initiate cell cycle reentry.10 We have also shown that overexpression of GATA-6 gene induced cell cycle arrest in VSMCs and fibroblasts.11 These results suggest that GATA-6 is a candidate gene that may be implicated in maintenance of the differentiated phenotype in VSMCs and that overexpression of GATA-6 can inhibit proliferation of VSMCs.
Cell cycle progression is regulated by cyclin-dependent kinase (cdk), the activities of which oscillate during the cell cycle. Cdks are regulated by cyclins, positive coactivators, and cdk inhibitors.12 13 In mammalian cells, cyclin Dcdk4/cdk6, cyclin Ecdk2, cyclin Acdk2, and cyclin Bcdc2 are the main cyclin-cdk complexes that regulate the progression of G1, G1/S, S, and G2/M phases, respectively. Cdk inhibitors comprise 2 families, the ink4 and cip/kip families. Cdk inhibitors of the cip/kip family are of particular interest in that they inhibit the activity of a broader spectrum of cdks, including cdk2, cdk4, and cdk6. The cip/kip family is composed of p21cip1, p27kip1, and p57kip2.14 15 16
Given that GMCs and VSMCs have similar properties, it is tempting to speculate that the GATA-6 transcription factor may participate in maintenance of the quiescent phenotype in GMCs. To test the hypothesis, we examined whether the GATA-6 gene was expressed in GMCs and whether overexpression of GATA-6 inhibited GMC proliferation using a replication-defective adenovirus (Ad) expressing GATA-6.
| Materials and Methods |
|---|
|
|
|---|
Plasmids
Details of the subcloning of hemagglutinin (HA) epitopetagged
human GATA-6 cDNA in a mammalian expression vector (pcDNA3HA-hGATA-6),
isolation of the human cyclin A cDNA, and preparation of the
full-length p21cip1 cDNA are described elsewhere
(see online-only supplementary information; data supplement available
at http://www.circresaha.org).
Construction of a Replication-Defective Ad Encoding Human
GATA-6
Construction of a replication-defective Ad that expresses
HA-tagged human GATA-6 (Ad GATA-6) was performed according to the
cosmid cassettes and Ad DNA-terminal protein complex (COS-TPC)
method as previously described.18 A recombinant Ad
that expresses glomerular-filtered phosphate (green
fluorescent protein) was obtained from Quantum Biotechnologies.
Adenoviral Infection
Subconfluent GMCs were infected with Ad GATA-6 or Ad GFP in
low-serum medium (DMEM/0.1% FBS) with multiplicity of infection (MOI)
varying from 0 to 50. Cells were incubated in the low-serum medium for
72 hours and then restimulated with growth medium (DMEM/10% FBS) for
8, 16, and 24 hours.
RNA Extraction and Northern Blot Analysis
Total RNA was extracted using Trizol reagent (Gibco-BRL), and
poly(A) RNA was purified using SCIGEN mRNA isolation kit (SCIGEN)
according to the instructions provided by the manufacturer. Northern
blot analysis was performed as previously
described.17
Preparation of Protein Extracts
Protein extracts were prepared as previously
described.19
Western Blot Analysis
Western blot analysis was carried out as previously
described.19 Primary antibodies were used at a dilution of
1:100.
cdk2 Kinase Assays
The assays were performed as previously
described19 ; 75 µg of each protein extract was used for
the assays.
Measurement of [3H]thymidine Incorporation
[3H]thymidine incorporation was measured
as previously described.19
Statistical Analyses
Values are mean±SEM. The effects of adenoviral infection on
expression of cyclins/cdks/cdk inhibitors, cdk2 kinase
activities, and [3H]thymidine uptake were
assessed using ANOVA followed by the Student-Newman-Keuls test.
An expanded Materials and Methods section can be found in an online data supplement available at http://www.circresaha.org.
| Results |
|---|
|
|
|---|
8 hours after stimulation (19% expression compared with the
expression level at 0 hours). The GATA-6 expression returned to the
basal level 20 hours after stimulation.
|
GATA-6 Induces Growth Arrest in GMCs
To examine whether overexpression of GATA-6 induced growth arrest
in GMCs, GMCs were infected with a recombinant Ad expressing HA-tagged
human GATA-6 (Ad GATA-6). A recombinant Ad expressing GFP (Ad GFP) was
used as the negative control. In GMCs treated with Ad GFP or PBS,
stimulation with serum mitogen increased
[3H]thymidine incorporation in a time-dependent
manner (Figure 2A
). Infection with Ad
GATA-6, infected at an MOI of 50, completely suppressed a serum
mitogen-induced increase in [3H]thymidine
uptake to the basal level (P<0.01) (Figure 2A
). We
also examined the dose dependence of Ad GATA-6induced inhibition of
[3H]thymidine uptake. Ad GATA-6, infected at an
MOI varying from 0 to 100, inhibited serum mitogen-induced increase in
[3H]thymidine uptake in a dose-dependent manner
(Figure 2B
). Because the effect of Ad GATA-6 on cell growth
reached a plateau at 50 MOI, all subsequent experiments were performed
at 50 MOI unless otherwise specified.
|
GATA-6Induced Changes in the Expression of the Cell
CycleRegulatory Factors
We next examined the effects of Ad GATA-6 infection on the protein
expression levels of the cell cycleregulatory factors in GMCs (Figure 3
). Expression of HA-tagged GATA-6
protein in Ad GATA-6infected GMCs was confirmed by Western blot
analysis using anti-HA antibody. Expression of cyclin D1 was
induced by serum mitogen in a time-dependent manner, and Ad GATA-6
infection did not affect the induction, suggesting that the early
G1 phase progressed normally in Ad
GATA-6infected cells. In contrast, time-dependent induction of cyclin
A expression by serum mitogen was substantially inhibited by Ad GATA-6
infection. Consistent with previous
observations,20 expression of
p21cip1 was induced by serum mitogen in a
time-dependent fashion. However, expression of
p21cip1 was significantly higher in cells
infected with Ad GATA-6 compared with those infected with Ad GFP at
each time point examined (Ad GFP:Ad GATA-6=1:3.3±0.9, 8 hours after
stimulation [n=4, P<0.05]; 1:3.7±0.3, 16 hours after
stimulation [n=4, P<0.01]). Expression of cyclin E, cdk2,
cdk4, and p27kip1 did not change remarkably
during the time course, and Ad GATA-6 infection did not affect their
expression. We next examined whether amounts of cyclin A and
p21cip1 associated with cdk2 were indeed changed.
Protein extracts prepared from cells infected with Ad GATA-6 or Ad GFP
were immunoprecipitated with anti-cdk2 antibody and
immunoblotted with anticyclin A antibody or
anti-p21cip1 antibody. As shown in Figure 4
, the amount of cdk2-associated cyclin A
was lower in Ad GATA-6infected cells compared with that in Ad
GFPinfected cells (63% of control level), whereas the amount of
cdk2-associated p21cip1 was higher in Ad
GATA-6infected cells (340% of control level).
|
|
Overexpression of GATA-6 Inhibits cdk2 Kinase Activity
We examined whether Ad GATA-6 infection inhibited cdk2 kinase
activity. Anti-cdk2 antibody was used to immunoprecipitate total cdk2,
and kinase activity was measured using histone H1 as the substrate.
Serum mitogen induced cdk2 kinase activity in a time-dependent manner
in control cells infected with Ad GFP. In contrast, a serum
mitogeninduced increase in cdk2 kinase activity was inhibited to 41%
(16 hours after stimulation [n=4, P<0.01]) in Ad
GATA-6infected cells compared with that in Ad GFPinfected cells
(Figure 5
). We also examined cyclin
Aassociated cdk2 kinase activity and found that it was inhibited in
Ad GATA-6infected cells (see online Figure 1A
; online-only data
supplement available at http://www.circresaha.org). Furthermore, we
found that Ad GATA-6infected cells contained heat-stable
inhibitors of cdk2 activity that could be largely
immunodepleted with anti-p21cip1 antibody (see
online Figure 1B
; online-only data supplement available at
http://www.circresaha.org).
|
Overexpression of GATA-6 Inhibits Accumulation of Cyclin A
Transcripts and Stabilizes p21cip1 Protein
We next examined whether GATA-6induced increase of
p21cip1 expression and decrease of cyclin
A expression occurred at the level of mRNA or protein. We performed
Northern blot analysis using full-length human
p21cip1 cDNA and human cyclin A cDNA as probes. A
single cyclin A transcript was detected in GMCs. The accumulation of
cyclin A transcripts increased 20 hours after stimulation with serum
mitogen in Ad GFPinfected cells and remained increased until 32 hours
after stimulation, whereas the accumulation of cyclin A transcripts was
reduced significantly in Ad GATA-6infected cells (28±6% compared
with Ad GFP infection, 24 hours after stimulation [n=4,
P<0.05]) (Figure 6A
). In
contrast, GMCs appeared to express low levels of
p21cip1 transcripts, because
p21cip1 transcripts were not detected when total
RNA was used for the analysis (data not shown). We therefore
used poly(A) RNA extracted from GMCs that were stimulated with serum
mitogen for 20 hours. In these samples, infection with GATA-6 had
little or no effect on p21cip1 transcript levels
(Figure 6B
). The p21cip1 transcript levels
in Ad GATA-6infected GMCs increased 1.2-fold at the most, compared
with those in Ad GFPinfected GMCs, suggesting the
post-transcriptional regulation of p21cip1
expression. We therefore examined the stability of
p21cip1 protein in Ad GATA-6infected cells
(Figure 6C
). After induction of p21cip1
protein by stimulation with serum mitogen for 16 hours, 10 µg/mL of
cycloheximide (CHX) was added to the medium, and the time course of the
expression of p21cip1 protein was examined. The
expression of p21cip1 in Ad GFPinfected cells
decreased rapidly (30% of control level, 30 minutes after incubation
with CHX), whereas that in Ad GATA-6infected cells was relatively
stable (85% of control level, 30 minutes after incubation with CHX),
suggesting stabilization of p21cip1 protein in Ad
GATA-6infected cells.
|
GATA-6Induced Inhibition of Cell Cycle Progression and the
Accumulation of Cyclin A Transcripts Depend on p21cip1
Expression
We finally examined whether GATA-6induced inhibition of cell
cycle progression and cyclin A gene expression depended on the presence
of p21cip1. GMCs obtained from wild-type and
p21cip1/ mice were infected with Ad GATA-6 or
Ad GFP, and [3H]thymidine uptake was examined
16 hours after stimulation of quiescent GMCs with serum mitogen. Forced
expression of GATA-6 significantly inhibited
[3H]thymidine uptake in GMCs obtained from
wild-type mice, whereas GATA-6 overexpression did not significantly
inhibit [3H]thymidine uptake in GMCs obtained
from p21cip1/ mice (Figure 7A
). In accordance with the results, the
expression of cyclin A transcripts in wild-type GMCs was inhibited by
GATA-6 overexpression (55% expression compared with Ad GFP infection,
24 hours after stimulation), whereas that in
p21cip1/ GMCs was not remarkably inhibited by
GATA-6 overexpression (93% expression compared with Ad GFP infection,
24 hours after stimulation) (Figure 7B
), suggesting that
GATA-6induced inhibition of the cyclin A expression depended on
p21cip1 expression.
|
| Discussion |
|---|
|
|
|---|
Several data presented in this study suggested that
upregulation of p21cip1 was implicated in growth
arrest induced by GATA-6 overexpression in GMCs. We have shown
previously that GATA-6 induced growth arrest in VSMCs as well as in
fibroblasts and that it was associated with
p21cip1 upregulation.11 Thus,
upregulation of p21cip1 appears to be a general
mechanism by which GATA-6 induces cell cycle arrest. Several factors,
including MyoD, CCAAT/enhancer binding protein
, vitamin
D3 receptor, Gax, and the tumor
suppressor BRCA1 reportedly induced p21cip1
expression, and the induction of p21cip1
correlates with growth arrest or
differentiation.21 22 23 24 25 Most of these factors induce
p21cip1 upregulation by stimulating transcription
of the p21cip1 gene. In contrast, transcriptional
regulation did not appear to play a major role in GATA-6induced
upregulation of p21cip1, because the accumulation
of p21cip1 transcripts did not change remarkably
compared with the changes in the amounts of
p21cip1 protein. Furthermore,
p21cip1 protein was stabilized in GMCs infected
with GATA-6. These data suggest that the induction of
p21cip1 by GATA-6 is largely regulated at a
post-transcriptional level. Along these lines, it is noteworthy that
CCAAT/enhancer binding protein
stabilizes
p21cip1 protein.22
We have also demonstrated, for the first time, that expression of cyclin A, but not of cyclin D1 or cyclin E, was specifically inhibited by GATA-6 infection. In contrast with p21cip1, the level of cyclin A transcripts was remarkably influenced by GATA-6 infection. The serum mitogeninduced accumulation of cyclin A transcripts was significantly inhibited by infection with Ad GATA-6, suggesting that the suppression of cyclin A occurred at the transcriptional level. However, because it was possible that GATA-6induced inhibition of cyclin A expression might be related to cell cycle arrest induced by p21cip1 upregulation, we examined cyclin A expression in the absence of p21cip1. Our results demonstrated that GATA-6 overexpression did not inhibit cell growth or the accumulation of cyclin A transcripts in p21cip1/ GMCs, suggesting that GATA-6induced suppression of cyclin A expression depended on p21cip1 expression. The results also suggested that GATA-6induced inhibition of cyclin A expression might be a secondary effect of cell cycle arrest induced by p21cip1 upregulation rather than a direct effect of GATA-6 on the cyclin A expression (see online-only supplementary information; data supplement available at http://www.circresaha.org). However, it should be emphasized that GATA-6induced suppression of cyclin A expression appears to be a specific effect of GATA-6 rather than a nonspecific result of cell cycle arrest, because expression levels of other cell cycleregulatory factors were not affected by GATA-6 overexpression.
Several studies have shown that it is possible to modulate the proliferation of GMCs by modifying the cell cycleregulatory genes.26 27 28 Here, we have shown that GATA-6 is an endogenous factor in GMCs that can modulate the proliferation of these cells. GATA-6induced growth arrest of GMCs was associated with inhibition of cyclin A expression and p21cip1 upregulation. Therefore, modulation of GATA-6 gene expression in kidney may be a useful strategy to treat the progression of mesangial proliferative glomerulonephritis.
| Acknowledgments |
|---|
Received May 15, 2000; revision received August 21, 2000; accepted August 21, 2000.
| References |
|---|
|
|
|---|
2. Michael AF, Keane WF, Raij L, Vernier RL, Mauer SM. The glomerular mesangium. Kidney Int. 1980;17:141154.[Medline] [Order article via Infotrieve]
3. Simon MC. Gotta have GATA. Nat Genet. 1995;11:911.[Medline] [Order article via Infotrieve]
4. Pevny L, Simon MC, Robertson E, Klein WH, Tsai S-F, DAgati V, Orkin SH, Costantini F. Erythroid differentiation in chimeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature. 1991;349:257260.[Medline] [Order article via Infotrieve]
5. Tsai F-Y, Keller G, Kuo FC, Weiss M, Chen J, Rosenblatt M, Alt FW, Orkin SH. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature. 1994;371:221226.[Medline] [Order article via Infotrieve]
6. Pandolfi PP, Roth ME, Karis A, Leonard MW, Dzierzak E, Grosveld FG, Engel JD, Lindenbaum MH. Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nat Genet. 1995;11:4044.[Medline] [Order article via Infotrieve]
7.
Kuo CT, Morrisey EE, Anandappa R, Sigrist K, Lu MM,
Parmacek MS, Soudais C, Leiden JM. GATA4 transcription factor is
required for ventral morphogenesis and heart tube formation.
Genes Dev. 1997;11:10481060.
8.
Reiter J, Alexander J, Rodaway A, Yelon D, Patient R,
Holder N, Stainier D. Gata5 is required for the development of the
heart and endoderm in zebrafish. Genes Dev. 1999;13:29832995.
9.
Morrisey EE, Tang Z, Sigrist K, Lu MM, Jiang F, Ip HS,
Parmacek MS. GATA6 regulates HNF4 and is required for differentiation
of visceral endoderm in the mouse embryo. Genes Dev. 1998;12:35793590.
10. Suzuki E, Evans T, Lowry J, Truong L, Bell DW, Testa JR, Walsh K. The human GATA-6 gene: structure, chromosomal location, and regulation of expression by tissue-specific and mitogen-responsive signals. Genomics. 1996;38:283290.[Medline] [Order article via Infotrieve]
11.
Perlman H, Suzuki E, Simonson M, Smith R, Walsh K.
GATA-6 induces p21cip1 expression and
G1 cell cycle arrest. J Biol
Chem. 1998;273:1371313718.
12. Pines J. Cyclins and cyclin-dependent kinases: a biochemical view. Biochem J. 1995;308:697711.
13.
Sherr CJ, Roberts JM. Inhibitors of
mammalian G1 cyclin-dependent kinases.
Genes Dev. 1995;9:11491163.
14. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993;75:817825.[Medline] [Order article via Infotrieve]
15.
Lee M-H, Reynisdottir I, Massague J. Cloning of
p57KIP2, a cyclin-dependent kinase
inhibitor with unique domain structure and tissue
distribution. Genes Dev. 1995;9:639649.
16. Polyak K, Lee M-H, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massague J. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 1994;78:5966.[Medline] [Order article via Infotrieve]
17. Nagata D, Hirata Y, Suzuki E, Kakoki M, Hayakawa H, Goto A, Ishimitsu T, Minamino N, Ono Y, Kangawa K, Matsuo H, Omata M. Hypoxia-induced adrenomedullin production in the kidney. Kidney Int. 1999;55:12591267.[Medline] [Order article via Infotrieve]
18.
Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y,
Takamori K, Tokuda C, Saito I. Efficient generation of recombinant
adenoviruses using adenovirus DNA-terminal protein complex and a cosmid
bearing the full-length virus genome. Proc Natl Acad Sci
U S A. 1996;93:13201324.
19.
Suzuki E, Nagata D, Kakoki M, Hayakawa H, Goto A, Omata
M, Hirata Y. Molecular mechanisms of endothelin-1-induced cell-cycle
progression: involvement of extracellular signal-regulated kinase,
protein kinase C, and phosphatidylinositol 3-kinase at distinct points.
Circ Res. 1999;84:611619.
20. Olson MF, Paterson HF, Marshall CJ. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature. 1998;394:295299.[Medline] [Order article via Infotrieve]
21.
Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J,
Hannon GJ, Beach D, Lassar AB. Correlation of terminal cell cycle
arrest of skeletal muscle with induction of p21 by MyoD.
Science. 1995;267:10181021.
22.
Timchenko NA, Wilde M, Nakanishi M, Smith JR,
Darlington GJ. CCAAT/enhancer-binding protein
(C/EBP
)
inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1)
protein. Genes Dev. 1996;10:804815.
23.
Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP.
Transcriptional activation of the Cdk inhibitor p21 by
vitamin D3 leads to the induced differentiation of the myelomonocytic
cell line U937. Genes Dev. 1996;10:142153.
24.
Smith RC, Branellec D, Gorski DH, Guo K, Perlman H,
Dedieu JF, Pastore C, Mahfoudi A, Denefle P, Isner JM, Walsh K,
p21CIP1-mediated inhibition of cell proliferation
by overexpression of the gax homeodomain gene. Genes Dev. 1997;11:16741689.
25. Somasundaram K, Zhang H, Zeng YX, Houvras Y, Peng Y, Zhang H, Wu GS, Licht JD, Weber BL, El-Deiry WS. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature. 1997;389:187190.[Medline] [Order article via Infotrieve]
26. Pippin JW, Qu Q, Meijer L, Shankland SJ. Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist. J Clin Invest. 1997;100:25122520.[Medline] [Order article via Infotrieve]
27. Terada Y, Yamada T, Nakashima O, Tamamori M, Ito H, Sasaki S, Marumo F. Overexpression of cell cycle inhibitors (p16INK4 and p21Cip1) and cyclin D1 using adenovirus vectors regulates proliferation of rat mesangial cells. J Am Soc Nephrol. 1997;8:5160.[Abstract]
28. Maeshima Y, Kashihara N, Yasuda T, Sugiyama H, Sekikawa T, Okamoto K, Kanao K, Watanabe Y, Kanwar YS, Makino H. Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo. J Clin Invest. 1998;101:25892597.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
Y. Y. Hui and H. A. LaVoie GATA4 Reduction Enhances 3',5'-Cyclic Adenosine 5'-Monophosphate-Stimulated Steroidogenic Acute Regulatory Protein Messenger Ribonucleic Acid and Progesterone Production in Luteinized Porcine Granulosa Cells Endocrinology, November 1, 2008; 149(11): 5557 - 5567. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Viger, S. M. Guittot, M. Anttonen, D. B. Wilson, and M. Heikinheimo Role of the GATA Family of Transcription Factors in Endocrine Development, Function, and Disease Mol. Endocrinol., April 1, 2008; 22(4): 781 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kamnasaran, B. Qian, C. Hawkins, W. L. Stanford, and A. Guha From the Cover: GATA6 is an astrocytoma tumor suppressor gene identified by gene trapping of mouse glioma model PNAS, May 8, 2007; 104(19): 8053 - 8058. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bielinska, S. Kiiveri, H. Parviainen, S. Mannisto, M. Heikinheimo, and D. B. Wilson Gonadectomy-induced Adrenocortical Neoplasia in the Domestic Ferret (Mustela putorius furo) and Laboratory Mouse. Vet. Pathol., February 1, 2006; 43(2): 97 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bielinska, H. Parviainen, S. B. Porter-Tinge, S. Kiiveri, E. Genova, N. Rahman, I. T. Huhtaniemi, L. J. Muglia, M. Heikinheimo, and D. B. Wilson Mouse Strain Susceptibility to Gonadectomy-Induced Adrenocortical Tumor Formation Correlates with the Expression of GATA-4 and Luteinizing Hormone Receptor Endocrinology, September 1, 2003; 144(9): 4123 - 4133. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Nagata, M. Mogi, and K. Walsh AMP-activated Protein Kinase (AMPK) Signaling in Endothelial Cells Is Essential for Angiogenesis in Response to Hypoxic Stress J. Biol. Chem., August 15, 2003; 278(33): 31000 - 31006. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ketola, J. Toppari, T. Vaskivuo, R. Herva, J. S. Tapanainen, and M. Heikinheimo Transcription Factor GATA-6, Cell Proliferation, Apoptosis, and Apoptosis-Related Proteins Bcl-2 and Bax in Human Fetal Testis J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1858 - 1865. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Morrisey GATA-6: The Proliferation Stops Here : Cell Proliferation in Glomerular Mesangial and Vascular Smooth Muscle Cells Circ. Res., October 13, 2000; 87(8): 638 - 640. [Full Text] [PDF] |
||||
![]() |
Q. Liang, L. J. De Windt, S. A. Witt, T. R. Kimball, B. E. Markham, and J. D. Molkentin The Transcription Factors GATA4 and GATA6 Regulate Cardiomyocyte Hypertrophy in Vitro and in Vivo J. Biol. Chem., August 3, 2001; 276(32): 30245 - 30253. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |